Sanofi India Limited updates on proposed divestment of Soframycin® and Sofradex® businesses Posted On: 2021-02-05 07:32:26 (Time Zone: Arizona, USA) The Board of the Directors of Sanofi India Limited (the Company) at its meeting held today, reviewed the proposed plan of the Sanofi Group to globally sell some of its old brands along with their trademarks, which are owned by Sanofi Group. These include brands Soframycin® and Sofradex®, which are manufactured (through a third-party manufacturing arrangement) and distributed by the Company. The Board also noted that upon completion of such sale by Sanofi Group, the Company will not have the authority to distribute products under these brands.